Literature DB >> 22146627

Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study.

Zhen-Yu Liu1, Yan-Ming Zhou, Le-Hua Shi, Zheng-Feng Yin.   

Abstract

BACKGROUND: Why 3.3% to 10% of all patients with hepatolithiasis develop intrahepatic cholangiocarcinoma (ICC) remains unknown. We carried out a hospital-based case-control study to identify risk factors for the development of ICC in patients with hepatolithiasis in China.
METHODS: Eighty-seven patients with pathologically diagnosed hepatolithiasis associated with ICC and 228 with hepatolithiasis alone matched by sex, age (+/-2 years), hospital admittance and place of residence were interviewed during the period of 2000-2008. Odds ratios (OR) and 95% confidence intervals (CI) were calculated for each risk factor.
RESULTS: Among the patients with hepatolithiasis associated with ICC, the mean age was 57.7 years and 61.0% were female. Univariate analysis showed that the significant risk factors for ICC development in hepatolithiasis were smoking, family history of cancer, appendectomy during childhood (under age 20), and duration of symptoms >10 years. In multivariate stepwise logistic regression analysis, smoking (OR=1.931, 95% CI: 1.000-3.731), family history of cancer (OR=5.175, 95% CI: 1.216-22.022), and duration of symptoms >10 years (OR=2.348, 95% CI: 1.394-3.952) were independent factors.
CONCLUSION: Smoking, family history of cancer and duration of symptoms >10 years may be risk factors for ICC in patients with hepatolithiasis.

Entities:  

Mesh:

Year:  2011        PMID: 22146627     DOI: 10.1016/s1499-3872(11)60106-9

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  19 in total

1.  Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones.

Authors:  Ze-Wu Meng; Sheng-Hua Han; Jin-Hai Zhu; Liang-Yi Zhou; Yan-Ling Chen
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

2.  Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones.

Authors:  Hyun Jung Kim; Tae Uk Kang; Heather Swan; Min Ji Kang; Nayoung Kim; Hyeong Sik Ahn; Seon Mee Park
Journal:  Dig Dis Sci       Date:  2018-08-31       Impact factor: 3.199

3.  Epidemiology and Risk Factors of Cholangiocarcinoma.

Authors:  Martha M Kirstein; Arndt Vogel
Journal:  Visc Med       Date:  2016-12-01

4.  Hepatolithiasis: clinical series, review and current management strategy.

Authors:  Osman Nuri Dilek; Ahmet Atasever; Nihan Acar; Şebnem Karasu; Emine Özlem Gür; Oğuzhan Özşay; Hakan Çamyar; Fatma Hüsniye Dilek
Journal:  Turk J Surg       Date:  2020-12-29

5.  Development and validation of a machine learning-based nomogram for prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis.

Authors:  Xian Shen; Huanhu Zhao; Xing Jin; Junyu Chen; Zhengping Yu; Kuvaneshan Ramen; Xiangwu Zheng; Xiuling Wu; Yunfeng Shan; Jianling Bai; Qiyu Zhang; Qiqiang Zeng
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

Review 6.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.

Authors:  Hyo Jung Kim; Jae Seon Kim; Moon Kyung Joo; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

7.  Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.

Authors:  Chia-Cheng Lin; Ping-Yi Lin; Yao-Li Chen
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

8.  High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study.

Authors:  Jung Hyun Jo; Moon Jae Chung; Jeong Youp Park; Seungmin Bang; Seung Woo Park; Kyung Sik Kim; Woo Jung Lee; Si Young Song; Jae Bock Chung
Journal:  Surg Endosc       Date:  2013-06-13       Impact factor: 4.584

9.  The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma.

Authors:  Haowen Tang; Zhanbo Wang; Wenping Lv; Xuan Meng
Journal:  Intractable Rare Dis Res       Date:  2018-05

10.  Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis.

Authors:  Yanming Zhou; Yanfang Zhao; Bin Li; Jiyi Huang; Lupeng Wu; Donghui Xu; Jiamei Yang; Jia He
Journal:  BMC Cancer       Date:  2012-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.